Russell Investments Group

Etalon Diagnostics is a biotechnology company focused on enhancing the health and performance of horses through advanced genetic diagnostic tools. The company offers comprehensive diagnostic panels that assess stress, disease, and biological age, alongside identifying genetic markers. By leveraging cutting-edge science, big data, and interactive crowdsourcing, Etalon Diagnostics produces leading genetic profiles that support the health and breeding of horses. Their proprietary platform collaborates with horse owners, trainers, and veterinarians to facilitate accelerated genetic discovery and DNA analysis. Among the services provided are diagnostics, ancestry assessments, and breeding or sale packages, all aimed at improving equine welfare and performance.

NextCapital is a Chicago-based company founded in 1996 that specializes in providing personalized financial planning and managed account services to individual investors. The company operates a digital advice platform that offers an open-architecture solution, integrating account aggregation, analytics, planning, and portfolio management. This platform allows clients to access tailored services for various investment needs, including 401(k), IRA, and taxable brokerage accounts. NextCapital partners with established institutions to deliver these services, enabling customization of advice methodology and fiduciary roles. The focus on affordability ensures that a broad range of investors can benefit from their offerings.

NextCapital is a Chicago-based company founded in 1996 that specializes in providing personalized financial planning and managed account services to individual investors. The company operates a digital advice platform that offers an open-architecture solution, integrating account aggregation, analytics, planning, and portfolio management. This platform allows clients to access tailored services for various investment needs, including 401(k), IRA, and taxable brokerage accounts. NextCapital partners with established institutions to deliver these services, enabling customization of advice methodology and fiduciary roles. The focus on affordability ensures that a broad range of investors can benefit from their offerings.

Pantheon Ventures (UK) LLP is a private equity firm founded in 1982 and based in London, with additional offices in North America, Asia, and South America. The firm specializes in direct investments and fund-of-funds across various asset classes, including private equity, infrastructure, and real assets. Pantheon targets a diverse range of investment opportunities, focusing on venture capital, buyouts, secondaries, and special situations, particularly in the United States, Europe, and Asia. It typically co-invests between $10 million and $50 million, and its investment strategies encompass early and late-stage venture capital, as well as distressed debt and restructuring. With approximately $24.1 billion in assets under management, Pantheon serves over 400 institutional investors, including pension plans and foundations. The firm employs a rigorous due diligence process and has built a robust network of relationships across its global markets, enabling it to effectively monitor its investments. Pantheon also structures customized separate account programs for high-net-worth individuals and institutional clients, with a focus on tailored investment solutions.